Featured
The Hepatitis A, B and C in NYC: 2023 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
Featured
NASTAD Building a Coalition to Support Viral Hepatitis Elimination Toolkit poses questions related to coalition purpose, structure and responsibilities for jurisdictions.
NASTAD Managing Power Dynamics Within the Coalition Toolkit outlines coalition structures and how viral hepatitis programs can equitably share power with community organizations, people with lived experience, and advocates.
The Hepatitis A, B and C in NYC: 2023 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
SAMSHA and the CDC urges public health and substance use disorder (SUD) treatment communities to increase the number of people tested and treated for HIV and viral hepatitis.
The Hepatitis A, B and C in NYC: 2022 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
The Hepatitis A, B and C in NYC: 2021 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
In 2020, the USPSTF and the CDC recommended universal screening for Hep C during each pregnancy. Children who have been exposed to Hep C perinatally should be tested.
Plan sets forth strategies to reduce new Hep C infections by 90%, premature deaths among people with Hep B & Hep C by 65%, and health inequities related to viral hepatitis. Health Department to partner with Hep Free NYC coalition on plan implementation.
In 2020, the USPSTF and the CDC recommended universal screening for Hep C during each pregnancy. Children who have been exposed to Hep C perinatally should be tested.
